FDA Inspection
Apnar Pharma LLPApnar Pharma LLP – FDA Inspection, May 22, 2026
Record Details
This FDA Inspection record concerns Apnar Pharma LLP, with an inspection on May 22, 2026, issued by the New Jersey District Office, covering human drugs.
- Person
View Company Profile
ID · 2e3ecc9e-96a0-4a56-a416-b610ed28e8c8
Inspection Facts
- Inspection number
- 1301816
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Apnar Pharma LLP
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2015 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Apnar Pharma LLP
- FDA Inspection 1182133 - 2022-09-01
- FDA Inspection 932607 - 2015-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.